Literature DB >> 30111593

Poxviral protein E3-altered cytokine production reveals that DExD/H-box helicase 9 controls Toll-like receptor-stimulated immune responses.

Alan Dempsey1, Sinead E Keating1, Michael Carty1, Andrew G Bowie2.   

Abstract

Host pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs) detect viruses and other pathogens, inducing production of cytokines that cause inflammation and mobilize cells to control infection. Vaccinia virus (VACV) encodes proteins that antagonize these host innate immune responses, and elucidating the mechanisms of action of these viral proteins helped shed light on PRR signaling mechanisms. The VACV virulence factor E3 is one of the most intensely studied VACV proteins and has multiple effects on host cells, many of which cannot be explained by the currently known cellular targets of E3. Here, we report that E3 expression in human monocytes alters TLR2- and TLR8-dependent cytokine induction, and particularly inhibits interleukin (IL)-6. Using MS, we identified DExD/H-box helicase 9 (DHX9) as an E3 target. Although DHX9 has previously been implicated as a PRR for sensing nucleic acid in dendritic cells, we found no role for DHX9 as a nucleic acid-sensing PRR in monocytes. Rather, DHX9 suppression in these cells phenocopied the effects of E3 expression on TLR2- and TLR8-dependent cytokine induction, in that DHX9 was required for all TLR8-dependent cytokines measured, and for TLR2-dependent IL-6. Furthermore, DHX9 also had a cell- and stimulus-independent role in IL-6 promoter induction. DHX9 enhanced NF-κB-dependent IL-6 promoter activation, which was directly antagonized by E3. These results indicate new roles for DHX9 in regulating cytokines in innate immunity and reveal that VACV E3 disrupts innate immune responses by targeting of DHX9.
© 2018 Dempsey et al.

Entities:  

Keywords:  DExD/H-box helicase (DHX9); Immune evasion; NF-κB (NF-KB); host-pathogen interaction; innate immunity; interleukin 6 (IL-6); pattern recognition receptor (PRR); poxvirus; signal transduction; toll-like receptor (TLR)

Mesh:

Substances:

Year:  2018        PMID: 30111593      PMCID: PMC6166711          DOI: 10.1074/jbc.RA118.005089

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  The vaccinia virus E3L gene product interacts with both the regulatory and the substrate binding regions of PKR: implications for PKR autoregulation.

Authors:  T V Sharp; F Moonan; A Romashko; B Joshi; G N Barber; R Jagus
Journal:  Virology       Date:  1998-10-25       Impact factor: 3.616

2.  RNA helicase A mediates association of CBP with RNA polymerase II.

Authors:  T Nakajima; C Uchida; S F Anderson; C G Lee; J Hurwitz; J D Parvin; M Montminy
Journal:  Cell       Date:  1997-09-19       Impact factor: 41.582

3.  A cellular cofactor for the constitutive transport element of type D retrovirus.

Authors:  H Tang; G M Gaietta; W H Fischer; M H Ellisman; F Wong-Staal
Journal:  Science       Date:  1997-05-30       Impact factor: 47.728

4.  Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.

Authors:  Keith B Gorden; Kevin S Gorski; Sheila J Gibson; Ross M Kedl; William C Kieper; Xiaohong Qiu; Mark A Tomai; Sefik S Alkan; John P Vasilakos
Journal:  J Immunol       Date:  2005-02-01       Impact factor: 5.422

5.  Sam68, RNA helicase A and Tap cooperate in the post-transcriptional regulation of human immunodeficiency virus and type D retroviral mRNA.

Authors:  T R Reddy; H Tang; W Xu; F Wong-Staal
Journal:  Oncogene       Date:  2000-07-27       Impact factor: 9.867

6.  Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model.

Authors:  T A Brandt; B L Jacobs
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

7.  Biological function of the vaccinia virus Z-DNA-binding protein E3L: gene transactivation and antiapoptotic activity in HeLa cells.

Authors:  Jin-Ah Kwon; Alexander Rich
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-26       Impact factor: 11.205

8.  Identification of RNA helicase A as a cellular factor that interacts with influenza A virus NS1 protein and its role in the virus life cycle.

Authors:  Li Lin; Yang Li; Hyun-Mi Pyo; Xinya Lu; Sathya N Thulasi Raman; Qiang Liu; Earl G Brown; Yan Zhou
Journal:  J Virol       Date:  2011-12-14       Impact factor: 5.103

9.  RNA helicase A is essential for normal gastrulation.

Authors:  C G Lee; V da Costa Soares; C Newberger; K Manova; E Lacy; J Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

10.  An antiviral response directed by PKR phosphorylation of the RNA helicase A.

Authors:  Anthony J Sadler; Olivier Latchoumanin; David Hawkes; Johnson Mak; Bryan R G Williams
Journal:  PLoS Pathog       Date:  2009-02-20       Impact factor: 6.823

View more
  8 in total

1.  Injection site vaccinology of a recombinant vaccinia-based vector reveals diverse innate immune signatures.

Authors:  Jessamine E Hazlewood; Troy Dumenil; Thuy T Le; Andrii Slonchak; Stephen H Kazakoff; Ann-Marie Patch; Lesley-Ann Gray; Paul M Howley; Liang Liu; John D Hayball; Kexin Yan; Daniel J Rawle; Natalie A Prow; Andreas Suhrbier
Journal:  PLoS Pathog       Date:  2021-01-13       Impact factor: 6.823

2.  Direct Phenotyping and Principal Component Analysis of Type Traits Implicate Novel QTL in Bovine Mastitis through Genome-Wide Association.

Authors:  Asha M Miles; Christian J Posbergh; Heather J Huson
Journal:  Animals (Basel)       Date:  2021-04-17       Impact factor: 2.752

Review 3.  DExD/H-box helicases: multifunctional regulators in antiviral innate immunity.

Authors:  Chenhe Su; Yan-Dong Tang; Chunfu Zheng
Journal:  Cell Mol Life Sci       Date:  2021-12-15       Impact factor: 9.261

Review 4.  Small Hero with Great Powers: Vaccinia Virus E3 Protein and Evasion of the Type I IFN Response.

Authors:  Mateusz Szczerba; Sambhavi Subramanian; Kelly Trainor; Megan McCaughan; Karen V Kibler; Bertram L Jacobs
Journal:  Biomedicines       Date:  2022-01-22

5.  System analysis based on the cancer-immunity cycle identifies ZNF207 as a novel immunotherapy target for hepatocellular carcinoma.

Authors:  Xu Wang; Tao Zhou; Xingyi Chen; Yu Wang; Yushi Ding; Haoyang Tu; Shengyang Gao; Haoyu Wang; Xinying Tang; Yong Yang
Journal:  J Immunother Cancer       Date:  2022-03       Impact factor: 13.751

6.  The A137R Protein of African Swine Fever Virus Inhibits Type I Interferon Production via the Autophagy-Mediated Lysosomal Degradation of TBK1.

Authors:  Maowen Sun; Shaoxiong Yu; Hailiang Ge; Tao Wang; Yongfeng Li; Pingping Zhou; Li Pan; Yu Han; Yuying Yang; Yuan Sun; Su Li; Lian-Feng Li; Hua-Ji Qiu
Journal:  J Virol       Date:  2022-04-12       Impact factor: 6.549

7.  RNA Helicase A/DHX9 Forms Unique Cytoplasmic Antiviral Granules That Restrict Oncolytic Myxoma Virus Replication in Human Cancer Cells.

Authors:  Masmudur M Rahman; Ami D Gutierrez-Jensen; Honor L Glenn; Mario Abrantes; Nissin Moussatche; Grant McFadden
Journal:  J Virol       Date:  2021-06-24       Impact factor: 5.103

Review 8.  Battle Royale: Innate Recognition of Poxviruses and Viral Immune Evasion.

Authors:  Huibin Yu; Ryan C Bruneau; Greg Brennan; Stefan Rothenburg
Journal:  Biomedicines       Date:  2021-07-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.